Cellectar Biosciences, Inc. Profile Avatar - Palmy Investing

Cellectar Biosciences, Inc.

Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), whic…

Biotechnology
US, Florham Park [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group

Peers Performance

A quick analysis that compared Cellectar Biosciences, Inc. (CLRB) to it's peer group.

Peer Group
MNPR PULM NXTC DFFN CAPR BPTH AMTI ALRN BOLT TENX BNTC CBIO LUMO LBPH Compare Together
Loading...
End of CLRB's Analysis
CIK: 1279704 CUSIP: 15117F500 ISIN: US15117F8077 LEI: - UEI: -
Secondary Listings
CLRB has no secondary listings inside our databases.